Study reveals decline in adolescent marijuana use over a decade

Marijuana has emerged as one of the most commonly used illicit substances among adolescents in the United States.

Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics – Biotech Investments

Heidelberg Pharma AG / Key word(s): Miscellaneous Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics 29-Jun-2023 / 09:45 CET/CEST Disclosure of an inside information acc.

June 29, 2023

Cybin Completes Enrollment in Phase 2 Study of CYB003 in Major Depressive Disorder | Psychedelic Invest

–Phase 2 topline efficacy data for CYB003 on track for Q4 2023, followed by U.S. Food and Drug Administration (“FDA”) submission of CYB003 Phase 1/2

September 21, 2023

Understanding human body composition in the first two years of life

Historical challenges associated with the assessment of body composition in the first two years of life.

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.